Millennium Management’s Gatos Silver, Inc. GATO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-845,861
Closed -$11.8M 6615
2024
Q4
$11.8M Buy
845,861
+562,242
+198% +$9.15M 0.01% 2021
2024
Q3
$4.28M Buy
283,619
+268,472
+1,772% +$3.44M ﹤0.01% 2981
2024
Q2
$158K Sell
15,147
-115,480
-88% -$1.22M ﹤0.01% 5220
2024
Q1
$1.1M Sell
130,627
-185,848
-59% -$1.24M ﹤0.01% 4215
2023
Q4
$2.07M Buy
316,475
+147,201
+87% +$817K ﹤0.01% 3575
2023
Q3
$877K Sell
169,274
-162,994
-49% -$783K ﹤0.01% 4277
2023
Q2
$1.26M Buy
332,268
+49,548
+18% +$267K ﹤0.01% 3855
2023
Q1
$1.85M Buy
282,720
+54,348
+24% +$261K ﹤0.01% 3526
2022
Q4
$934K Sell
228,372
-101,824
-31% -$370K ﹤0.01% 4232
2022
Q3
$885K Sell
330,196
-157,153
-32% -$492K ﹤0.01% 4440
2022
Q2
$1.4M Buy
487,349
+434,126
+816% +$1.52M ﹤0.01% 4055
2022
Q1
$229K Buy
+53,223
New +$293K ﹤0.01% 5754
2021
Q2
Sell
-284,157
Closed -$2.83M 7241
2021
Q1
$2.83M Sell
284,157
-531,999
-65% -$7.27M ﹤0.01% 3191
2020
Q4
$10.6M Buy
+816,156
New +$6.25M 0.01% 1664

Other funds holding GATO

Millennium Management's GATO Position: Q1 2025 in Review

Millennium Management sold out of Gatos Silver, Inc. (GATO) in Q1 2025, closing a stake of 845,861 shares — an estimated $11.8M sold.

Millennium Management first reported a position in GATO in Q4 2020 and held it in 14 quarters. The position peaked at $11.8M in Q4 2024. 3 funds tracked by Wall St. Rank hold GATO as of Q1 2025.

  • Millennium Management reported no remaining Gatos Silver, Inc. position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 845,861 Gatos Silver, Inc. shares in Q1 2025, an estimated $11.8M.
  • Millennium Management first reported a position in Gatos Silver, Inc. in Q4 2020 and held it in 14 quarters.
  • Millennium Management's Gatos Silver, Inc. position peaked at $11.8M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Gatos Silver, Inc. as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.